Genetic Testing for Cancer Risk: Understanding Your Inherited Blueprint for Prevention

Cancer develops through a complex combination of genetic, environmental and lifestyle factors. While behaviors such as smoking, alcohol consumption, diet, physical activity and exposure to certain harmful substances can influence cancer risk, inherited genetic variants can also make some individuals more susceptible to certain types of cancer.
Understanding whether you carry an inherited cancer-related genetic variant can provide valuable information for risk assessment, personalized screening and preventive healthcare.
Importantly, having a genetic variant associated with cancer does not necessarily mean that you will develop cancer. Instead, it may indicate that your risk is higher than that of the general population.
How Can You Check for Inherited Cancer Risk?
Genetic testing can analyze specific genes associated with hereditary cancer syndromes. Depending on the test, a sample may be collected through blood or saliva, while some testing services may use a cheek swab.
The sample is then analyzed for genetic variants known to be associated with an increased risk of certain cancers.
The time required to receive results varies depending on the laboratory and type of test. Some comprehensive DNA testing services may take several weeks to complete.
Because the meaning of genetic results can be complex, testing for hereditary cancer risk is ideally accompanied by consultation with a doctor or qualified genetic counselor, particularly when a clinically significant variant is identified.
What Types of Cancer Risk Can Genetic Testing Assess?
Depending on the genes included in the testing panel, hereditary cancer genetic testing may help assess predisposition to several cancers, including:
- Breast cancer
- Ovarian cancer
- Colorectal cancer
- Prostate cancer
- Pancreatic cancer
- Stomach cancer
- Kidney cancer
- Certain blood cancers
- Other cancers associated with specific hereditary cancer syndromes
For example, variants in BRCA1 and BRCA2 are associated with increased risks of breast, ovarian, prostate and pancreatic cancers, while variants in several DNA mismatch-repair genes are associated with Lynch syndrome, which increases the risk of colorectal and several other cancers.
However, genetic testing is not a cancer diagnosis. It identifies inherited variants that may influence an individual's future risk.
Who Should Consider Cancer-Risk Genetic Testing?
Genetic testing may be particularly useful for people with a personal or family history suggestive of hereditary cancer, such as:
- Several close relatives diagnosed with the same or related cancers
- Cancer occurring at an unusually young age
- Multiple primary cancers occurring in the same person
- Certain rare cancers
- A known cancer-associated genetic variant in the family
People without a strong family history may also consider genetic testing in some circumstances. However, whether testing is appropriate and which genes should be tested depends on personal and family medical history.
Discussing these factors with a healthcare professional can help determine the most appropriate testing strategy.
What Does a Positive Genetic Test Mean?
A positive result for a pathogenic or likely pathogenic cancer-associated variant does not mean that cancer is inevitable.
Different genetic variants carry different levels of risk, and cancer development can also be influenced by age, lifestyle, environmental exposures and other biological factors.
Depending on the specific gene and cancer risk identified, a healthcare professional may recommend:
- Starting cancer screening earlier
- Increasing the frequency of certain screening tests
- Using specialized imaging or other surveillance methods
- Lifestyle and risk-reduction strategies
- Preventive medication in selected situations
- Risk-reducing procedures for people with certain high-risk genetic variants
The appropriate strategy should be personalized according to the gene involved, the level of risk and the individual's medical and family history.
Genetics Can Help Guide Personalized Prevention
One of the greatest potential benefits of genetic testing is the opportunity to move toward more personalized preventive healthcare.
Knowing about an inherited cancer predisposition may allow individuals and their healthcare providers to develop a screening and prevention strategy based on their specific level of risk rather than relying solely on recommendations designed for the general population.
At the same time, healthy lifestyle choices remain important for reducing the risk of many cancers. Avoiding tobacco, limiting alcohol, maintaining a healthy body weight, staying physically active and following a balanced diet can contribute to overall cancer prevention.
Genetic information should therefore be viewed as one part of a broader health picture helping individuals better understand their inherited risk and make informed decisions together with qualified healthcare professionals.
Source :
TRIA Medical Wellness Center
이 기사 공유
더 많은 기사
건강 관리 및 의료 관광에 대한 더 많은 인사이트를 발견하세요.

아시아 코스메틱 병원의 Tanongsak Panyawirunroj 박사에 대해 알아보기: 수술의 이면
사람들이 성형수술을 생각할 때, 흔히 시술 후 눈에 보이는 결과, 즉 얼굴의 형태, 코, 눈, 유방 또는 신체의 윤곽에 먼저 주목합니다. 그러나 눈에 보이는 모든 변화 뒤에는 해부학적 지식, 수술 경험, 환자 평가, 그리고 수술 전, 중, 후에 이루어지는 일련의 의학적 결정이 관여하는 훨씬 더 복잡한 과정이 숨어 있습니다.

태국의 세포 치료: 중간엽 기질세포(MSCs)와 맞춤형 재생 치료 안내
세포 치료는 <strong>재생의학</strong> 분야 내에서 발전하고 있는 영역으로, 세포와 세포 유래 생물학적 기전이 조직 회복, 면역 조절 및 회복에 어떻게 기여할 수 있는지 연구합니다.

피곤한 채로 깨어나나요? 부신 피로의 신호일 수 있습니다
매일 아침, 부신은 조용히 호르몬을 생성하기 시작하며 하루를 새로 시작할 수 있도록 상쾌한 기분을 느끼게 해줍니다. 이는 사무실에서의 바쁜 일정이든, 아침 루틴을 즐길 수 있는 에너지든 마찬가지입니다. 그런데 하루를 위한 밝고 손쉬운 시작이 예전처럼 쉽게 찾아오지 않는 느낌이 들고, 평소 즐기던 일들조차 마치 노력이 필요한 것처럼 느껴진다면 주목할 가치가 있습니다. 이러한 변화는 종종 신체가 도움을 요청하는 방식이며, 때로는 ‘부신 피로(adrenal fatigue)’라고 불리기도 하는 신호이기도 합니다.